AbbVie (ABBV) Stock on November 29, 2025: Skyrizi’s Canada Win, Big-Money Flows and a Hot Valuation Debate

AbbVie (ABBV) Stock on November 29, 2025: Skyrizi’s Canada Win, Big-Money Flows and a Hot Valuation Debate

Published: November 29, 2025 AbbVie Inc. (NYSE: ABBV) heads into the final stretch of 2025 trading just below its record highs, after a powerful rally driven by immunology blockbuster drugs Skyrizi and Rinvoq. The stock closed at $227.70 on Friday, November 28, up 0.02% on the day and sitting within a 52‑week range of roughly $164 to $245. StockAnalysis+1 Year to date, AbbVie shares have climbed about 31–32%, and delivered roughly 38% over the past twelve months, easily outpacing the broader market. Simply Wall St+1 Today’s news flow (November 29, 2025) gives investors plenty to chew on: Below is a
Citigroup (C) Stock Update for November 29, 2025: Institutional Buying Wave, Data-Breach Fallout and a New Valuation Tug of War

Citigroup (C) Stock Update for November 29, 2025: Institutional Buying Wave, Data-Breach Fallout and a New Valuation Tug of War

As the market heads into the final stretch of 2025, Citigroup Inc. (NYSE: C) is going into the weekend trading just below its recent highs and firmly back on investors’ radar. The stock finished Friday, November 28, around $103.60, less than 2% below its 52‑week peak of $105.59 and almost double its 52‑week low of $55.51 set in April.FT Markets+1 At the same time, November 29 brought a flood of new 13F-based institutional ownership disclosures, renewed attention to a major third‑party data breach that touches Citi customers, and fresh debate over whether the stock is fairly valued or deeply undervalued.
Charles Schwab Stock (SCHW) on 29 November 2025: Forge Global Deal, ETF Platform Fees and Record Asset Growth Fuel Investor Debate

Charles Schwab Stock (SCHW) on 29 November 2025: Forge Global Deal, ETF Platform Fees and Record Asset Growth Fuel Investor Debate

Updated: November 29, 2025 Key takeaways Note: This article is for information only and is not financial advice or a recommendation to buy or sell any security. Charles Schwab stock today: price, trend and valuation As of the close on Friday, November 28, 2025, The Charles Schwab Corporation (NYSE: SCHW) traded at $92.73, up $0.93 on the session (+1.01%). Investing.com+1 From a performance angle, Barchart data show SCHW up about 24% year‑to‑date and 11.6% over the past 12 months, outpacing the Dow’s roughly 11.5% gain in 2025 and ~5.7% return over the past year. FinancialContent Different data providers quote slightly
PG Stock News Today (November 29, 2025): Hedge Funds Shuffle Positions as Procter & Gamble’s Valuation Comes Under the Microscope

PG Stock News Today (November 29, 2025): Hedge Funds Shuffle Positions as Procter & Gamble’s Valuation Comes Under the Microscope

Procter & Gamble Company (The) (NYSE: PG) heads into the weekend firmly in the spotlight. After closing on Friday, November 28, 2025 at $148.16 per share, down a marginal 0.06% on the day, the stock is trading much closer to its 52‑week low near $144 than its high around $180.MarketBeat+4PG Investor+4Investing.com+4 That price action comes despite solid recent earnings, an ongoing dividend yield of roughly 2.8% on an annualized payout of about $4.23 per share, and fresh product innovation in its Pantene franchise.Simply Wall St+3MarketBeat+3MarketBeat+3 Today’s PG stock news (November 29, 2025) coalesces around three big themes: Below is a
Booking Holdings (BKNG) Stock Today: Analyst Upgrades, Big-Name Buyers and Q3 Earnings Power – November 29, 2025

Booking Holdings (BKNG) Stock Today: Analyst Upgrades, Big-Name Buyers and Q3 Earnings Power – November 29, 2025

Booking Holdings Inc. Common Stock (NASDAQ: BKNG) is closing out November with a flurry of fresh institutional filings, new analyst commentary and lingering questions about how artificial intelligence will reshape online travel. As of the latest close on November 28, Booking Holdings stock trades around $4,914.69, up a fraction on the day and roughly 16% below its 52‑week high of $5,839.41. The company is valued at about $158 billion, trades on a price‑to‑earnings multiple near 32x, and offers a modest dividend yield of roughly 0.8% thanks to a quarterly payout of $9.60 per share. Investing.com+1 Below is a breakdown of
Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Date: November 29, 2025 Omnicom Group Inc. (NYSE: OMC) is entering one of the most important phases in its history. In the space of a few days, the company has: All of this is happening while Omnicom’s share price trades more than 30% below its 52‑week high, keeping the stock firmly on the radar of value‑oriented investors. StockAnalysis+1 Below is a rundown of the key current news around Omnicom stock as of November 29, 2025, and what it may mean for shareholders ahead of 2026. OMC stock today: trading near the low end of its 52‑week range As of the
Shopify Stock Today: Record Black Friday Sales, Big Money Flows and New Regulatory Risks – What Investors Need to Know (November 29, 2025)

Shopify Stock Today: Record Black Friday Sales, Big Money Flows and New Regulatory Risks – What Investors Need to Know (November 29, 2025)

On November 29, 2025, Shopify Inc. (NASDAQ: SHOP, TSX: SHOP) sits at the center of several powerful storylines: record-breaking Black Friday sales on its platform, fresh disclosures showing major institutional investors reshuffling their positions, a mixed but constructive Wall Street view, and mounting regulatory pressure over illegal vape sales. For investors tracking Shopify stock on Google News or Discover, today’s news flow offers a dense snapshot of both upside momentum and emerging risks. Here’s a detailed breakdown of everything that matters right now. Shopify stock snapshot: price, range and year‑to‑date performance Shopify’s U.S.-listed shares last closed at $158.64 on November
LEN Stock News Today (Nov. 29, 2025): Lennar’s Rebound, Millrose Exchange Offer and CEO Transition

LEN Stock News Today (Nov. 29, 2025): Lennar’s Rebound, Millrose Exchange Offer and CEO Transition

Lennar Corporation (NYSE: LEN), one of the largest U.S. homebuilders, heads into the final stretch of 2025 with its stock stabilizing around the mid‑$130s after a sharp rebound, a major share‑exchange deal, and a coming leadership change that will leave Executive Chairman Stuart Miller as sole CEO. TS2 Tech+1 Below is a comprehensive look at all the key Lennar stock news and context as of Saturday, November 29, 2025. Lennar Stock Snapshot as of November 29, 2025 U.S. markets were closed today, so the latest trading data for Lennar comes from Friday, November 28, 2025: The most eye‑catching move this
Goldman Sachs (GS) Stock Near Record Highs as Gold Bets, Labor-Market Warning and UK Expansion Collide

Goldman Sachs (GS) Stock Near Record Highs as Gold Bets, Labor-Market Warning and UK Expansion Collide

The Goldman Sachs Group, Inc. (NYSE: GS) — News and stock update for November 29, 2025 Goldman Sachs shares are heading into the last month of 2025 trading just shy of record territory, while a flurry of fresh headlines — from a warning on the U.S. jobs market to bold calls for $5,000 gold and a major UK hiring plan — reshapes the story investors are telling about GS stock today. On Friday, November 28, Goldman Sachs Group, Inc. closed at $826.04, up 1.23% for the day and logging a fifth straight session of gains. The stock finished about 1.8%
Boeing (BA) Stock on November 29, 2025: $189 Close, $7 Billion Pentagon Boost and a Starliner Cutback

Boeing (BA) Stock on November 29, 2025: $189 Close, $7 Billion Pentagon Boost and a Starliner Cutback

Boeing Company (The) (NYSE: BA) heads into the last days of November trading around $189 a share after a bruising but eventful month for investors. The stock is being pulled in opposite directions by more than $7 billion in new U.S. defense contracts, a sharply scaled‑back NASA Starliner deal, a major Airbus A320 software recall that reshapes the competitive backdrop, and fresh insider and institutional activity around the name. GuruFocus+4Nasdaq+4Investing.com+4 Below is a structured rundown of all the key Boeing stock news in play as of 29 November 2025, plus what it may mean for BA shareholders and watchers. Boeing
DELL Stock Today: Dell Technologies’ AI Boom, Memory Headwinds and Wall Street Outlook (November 29, 2025)

DELL Stock Today: Dell Technologies’ AI Boom, Memory Headwinds and Wall Street Outlook (November 29, 2025)

Dell Technologies Inc. (NYSE: DELL) is back in the spotlight this weekend after a week of big earnings, a raised AI outlook, fresh analyst calls and new 13F filings from major institutions. As of the latest close, the stock is trading in the low‑$130s while Wall Street debates whether Dell’s surging AI server business can outrun rising memory costs and a still‑cyclical PC market. Business Wire+1 Dell Technologies stock price on November 29, 2025 Price & performance As of the close on November 28, 2025, Dell Technologies shares were around $133.35, up a touch (about +0.07% on the day).MarketScreener+1 Recent
Marvell Technology (MRVL) Stock News Today: Insider Buying, New Institutional Stakes and UBS’s $110 Target – November 29, 2025

Marvell Technology (MRVL) Stock News Today: Insider Buying, New Institutional Stakes and UBS’s $110 Target – November 29, 2025

Marvell Technology, Inc. (NASDAQ: MRVL) is back in the spotlight as investors crowd into AI infrastructure names ahead of a key earnings report next week. The stock is trading around $89.40 per share today, giving the chipmaker a market capitalization in the mid‑$70 billion range and placing it near the upper end of its recent trading range but still below prior 52‑week highs. Investing.com+1 Fresh 13F filings released today, renewed commentary from Jim Cramer, and ongoing analyst debate — including UBS’s recently increased $110 price target — are all converging as Marvell heads into its fiscal Q3 2026 earnings report

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop